Oncofetal Biology: From Fundamental Mechanisms to Emerging Therapeutic Opportunities
MedComm – Oncology · 2026-06 · 5 (2)
DOI: 10.1002/mog2.70071 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm – Oncology, online erschienen am 19.05.2026. Verfasst von Yang Liu und 3 weiteren Autor:innen. Die Arbeit nennt 403 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The parallels between embryonic development and tumorigenesis have reshaped how we conceptualize cancer's molecular foundations. Once viewed as purely mutation‐driven, malignancy is now understood to involve the systematic reactivation of embryonic gene programs—raising a fundamental question: How extensively do tumors co‐opt developmental machinery to sustain their aggressive phenotypes? This review provides a comprehensive synthesis integrating developmental biology, reproductive medicine, and molecular oncology. It systematically examines how tumor cells exploit core developmental machinery, including pluripotency maintenance networks, evolutionarily conserved signaling pathways and epigenetic reprogramming mechanisms, such as DNA methylation, histone modifications, and non‐coding RNA regulation, to acquire stemness properties, drive epithelial‐mesenchymal transition (EMT), remodel the extracellular matrix (ECM), and establish immunosuppressive microenvironments. We further explore germ cell tumor biology, assisted reproductive technology (ART) implications, and DNA damage response vulnerabilities from a developmental perspective. These molecular insights furnish tangible opportunities: biomarker discovery rooted in fetal antigen re‐expression, and therapeutic strategies that selectively disrupt the “embryonic” state of cancer cells while sparing normal tissue. This review synthesizes the core molecular mechanisms connecting embryonic development and tumorigenesis from a multidisciplinary standpoint and outlines future research trajectories and clinical applications, thereby contributing new insights and actionable strategies in the fight against cancer.
Zitieren
APA
Liu, Y., Niu, K., Kong, Q., & Gao, S. (2026). Oncofetal Biology: From Fundamental Mechanisms to Emerging Therapeutic Opportunities. MedComm – Oncology, 5(2). https://doi.org/10.1002/mog2.70071
Vancouver
Liu Y, Niu K, Kong Q, Gao S. Oncofetal Biology: From Fundamental Mechanisms to Emerging Therapeutic Opportunities. MedComm – Oncology. 2026;5(2). doi:10.1002/mog2.70071
BibTeX
@article{Liu2026,
author = {Liu, Yang and Niu, Kaifeng and Kong, Qingran and Gao, Shaorong},
title = {Oncofetal Biology: From Fundamental Mechanisms to Emerging Therapeutic Opportunities},
journal = {MedComm – Oncology},
year = {2026},
volume = {5},
number = {2},
doi = {10.1002/mog2.70071}
}
EUVIMED